Trends in survival from colonic cancer: The impact of subspecialization

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 12, 1997, Pages 842-845

  Hoffmann, D ^a   Moore, J ^a   Roder, D ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b South Australian Cancer Registry   (Australia)

Author keywords

Cancer registry; Colonic cancer; Survival

Indexed keywords

ARTICLE; AUSTRALIA; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLON SURGERY; HUMAN; MAJOR CLINICAL STUDY;

EID: 0031470087     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb07608.x     Document Type: Article

References (21)

1. McArdle CS, Hole D, Hanseil D, Blumgart LH, Wood CB. Prospective study of colorectal cancer in the west of Scotland: Ten year followup. Br. J. Sitrg. 1990; 77: 280-2.
2. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br. Med. J. 1991; 302: 1501-5.
3. Carter DC. Lothian and Borders large bowel cancer project: Immediate outcome following surgery. Br. J. Sitrg. 1995; 82: 888-90.
4. Mella J, Biffen A, Radcliffe J, Stamatakis J, Steele RJC. Survival and local recurrence following elective rectal resection: Results from the Royal College of Surgeons audit. Int. J. Colorectal Dis. 1996; 11: 128.
5. Grabham JA, Coleman MG, Moss S, Thompson MR, Lane RHS. Wessex colorectal cancer audit: The effect of case volume on anastomotic leakage following anterior resection. Int. J. Colorectal Dis. 1996; 11: 132.
6. Thompson MR, Smith JAE, Lane RHS. Wessex colorectal cancer audit: The effect of volume and specialisation on intersurgeon variability. Int. J. Colorectal Dis. 1996; 11: 151.
7. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br. J. Surg. 1984; 71: 12-16. "
8. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakuline T, Esteve J (eds). Survival of Cancer Patients in Europe: The Eurocare Study. Lyon: International Agency for Research on Cancer, 1995.
9. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK (eds). SEER Cancer Statistics Review, 19731992: Tables and Graphs. Bethesda, MD: National Cancer Institute, 1995.
10. Miller BA, Ries LAG, Hankey BF et al. (eds). SEER Cancer
11. Statistics Review, 1973-1990. Bethesda, MD: National Cancer Institute, 1993.
12. South Australian Cancer Registry. Epidemiology of Cancer in South Australia. Incidence, Mortality and Survival 1977-1995. Incidence and Mortality 1995. Adelaide: Openbook Publishers, 1996.
13. Bonett A, Roder D, Estermann A. Cancer case survival rates for South Australia: A comparison with US rates and a preliminary investigation of time trends. Med. J. Aust. 1988; 148: 556-9.
14. Gill PG, Morris PJ. The survival of patients with colorectal cancer treated in a regional hospital. Br. J. Surg. 1978; 65: 17-20.
15. Deans GT, Parks TG, Rowlands BJ, Spence RA. Prognostic factors in colorectal cancer. Br. J. Surg. 1992; 79: 608-13.
16. Newland RC, Dent OF, Lyttle M, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994; 73: 2076-82.
17. Agrez MV, Spagnolo L, Harvey J, House AK, O'Connell D. Prognostic significance of lymphatic permeation in Dukes B colorectal cancer. Aust. N.Z. J. Surg. 1988; 58: 39-42.
18. Moertel CG, Fleming TR, McDonald JS et al. Levamisole and fluorouracil for adjuvant therapy for resected colon carcinoma. N. Engl. J. Med. 1990; 322: 352-8.
19. Houghton A. Variation in outcome of surgical procedures. Br. J. Surg. 1994; 81: 653-60.
20. National Institute of Health. Consensus Development Conference Draft Statement: Adjuvant Therapy for Patients with Colorectal Cancer. 1990.
21. IMPACT (International multicentre pooled analysis of colon cancer trials) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345: 939-44.